Back to Trades
Sell4
AMGEN INC
AMGN
Total Value
$2.1M
Net $1.1M sold
Sales
$1.1M
2 transactions
Company Information
- Company Name
- AMGEN INC
- Ticker Symbol
- AMGN
- CIK
- 0000318154
Insider Information
- Name
- Grygiel Nancy A.
- Role
- SVP & CCO
- Location
- THOUSAND OAKS, CA
Officer
Filing Details
- Filing Date
- Nov 21, 2025
- Transaction Date
- Nov 20, 2025
- Accession Number
- 0000318154-25-000083
- Form Type
- 4
- Net Trading Amount
- -$1.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 20, 2025 | Common Stock | 1,500 | $177.46 | Exercise | $266.2K |
| Nov 20, 2025 | Common Stock | 1,500 | $337.26 | Sale | $505.9K |
| Nov 20, 2025 | Common Stock | 1,639 | $162.60 | Exercise | $266.5K |
| Nov 20, 2025 | Common Stock | 1,639 | $337.26 | Sale | $552.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 20, 2025 | Derivative | 1,500 | $177.46 | Exercise | $266.2K |
| Nov 20, 2025 | Derivative | 1,639 | $162.60 | Exercise | $266.5K |
Footnotes
- (F1)The price reported is an average price. The prices ranged from $337.17 to $337.69 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- (F2)These shares include 96 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- (F3)These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.